Charlene Rigby 3/30/25 Charlene Rigby 3/30/25 STXBP1 Census - Q1 2025 Read More Russ Novy 3/28/25 Russ Novy 3/28/25 Small Town. Loud Voice. Read More Russ Novy 2/5/25 Russ Novy 2/5/25 What happens when a rare disease drug seems to work, but the health care system doesn’t? Read More Russ Novy 2/1/25 Russ Novy 2/1/25 Orphan Disease Center 2024 Million Dollar Bike Ride Grants - $139,416 for STXBP1 Research Awarded Read More Russ Novy 1/15/25 Russ Novy 1/15/25 STXBP1 Foundation Accelerates Growth with Addition of New Executive Director Read More Charlene Rigby 1/3/25 Charlene Rigby 1/3/25 STXBP1 Census - Q4 2024 Read More Charlene Rigby 11/3/24 Charlene Rigby 11/3/24 Capsida Biotherapeutics granted orphan drug designation for potential gene therapy for STXBP1-related disorders Read More Russ Novy 11/1/24 Russ Novy 11/1/24 FDA Grants Orphan Drug Designation to Capsida Biotherapeutics for Potential Treatment of STXBP1 Developmental and Epileptic Encephalopathy Read More Russ Novy 10/15/24 Russ Novy 10/15/24 Advancing Toward Gene Therapies for Rare Epilepsies Read More Russ Novy 10/2/24 Russ Novy 10/2/24 Newly Published “Voice of the Patient Report” Read More Older Posts
Russ Novy 2/5/25 Russ Novy 2/5/25 What happens when a rare disease drug seems to work, but the health care system doesn’t? Read More
Russ Novy 2/1/25 Russ Novy 2/1/25 Orphan Disease Center 2024 Million Dollar Bike Ride Grants - $139,416 for STXBP1 Research Awarded Read More
Russ Novy 1/15/25 Russ Novy 1/15/25 STXBP1 Foundation Accelerates Growth with Addition of New Executive Director Read More
Charlene Rigby 11/3/24 Charlene Rigby 11/3/24 Capsida Biotherapeutics granted orphan drug designation for potential gene therapy for STXBP1-related disorders Read More
Russ Novy 11/1/24 Russ Novy 11/1/24 FDA Grants Orphan Drug Designation to Capsida Biotherapeutics for Potential Treatment of STXBP1 Developmental and Epileptic Encephalopathy Read More